Literature DB >> 30719115

The role of the fat mass and obesity-associated protein in the proliferation of pancreatic cancer cells.

Xiaodong Tang1, Shuanghai Liu1, Dawei Chen1, Zhenguo Zhao1, Jiahua Zhou2.   

Abstract

Fat mass and obesity-associated (FTO) protein has been identified as a critical demethylase in regulating cellular mRNA stability by removing N6-methyladenosine (m6A) residues in mRNA. Even though the role of FTO in body energy metabolism has been well established, its role in cancer cell homeostasis remains unclear. In the present study, by using RNA interference, it was indicated that FTO is required for pancreatic cancer cell proliferation. Knockdown of FTO resulted in compromised proliferation of pancreatic cancer cells. Furthermore, DNA synthesis was compromised, followed by an increase in apoptosis in FTO small interfering RNA (siRNA)-treated cells. In terms of its underlying mechanism, FTO has been indicated to interact with MYC proto-oncogene, bHLH transcription factor and to enhance its stability by decreasing its m6A level. Therefore, the aforementioned observations indicate a novel mechanism for the regulation of pancreatic cancer cells by FTO, which may provide insight on pancreatic cancer treatment strategies.

Entities:  

Keywords:  fat mass and obesity-associated protein; pancreatic cancer; proliferation

Year:  2018        PMID: 30719115      PMCID: PMC6350187          DOI: 10.3892/ol.2018.9873

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.

Authors:  C M Wei; A Gershowitz; B Moss
Journal:  Cell       Date:  1975-04       Impact factor: 41.582

3.  Crystal structure of the FTO protein reveals basis for its substrate specificity.

Authors:  Zhifu Han; Tianhui Niu; Junbiao Chang; Xiaoguang Lei; Mingyan Zhao; Qiang Wang; Wei Cheng; Jinjing Wang; Yi Feng; Jijie Chai
Journal:  Nature       Date:  2010-04-07       Impact factor: 49.962

4.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

5.  Inactivation of the Fto gene protects from obesity.

Authors:  Julia Fischer; Linda Koch; Christian Emmerling; Jeanette Vierkotten; Thomas Peters; Jens C Brüning; Ulrich Rüther
Journal:  Nature       Date:  2009-02-22       Impact factor: 49.962

Review 6.  Surgical treatment of pancreatic cancer.

Authors:  Martin Loos; Jörg Kleeff; Helmut Friess; Markus W Büchler
Journal:  Ann N Y Acad Sci       Date:  2008-09       Impact factor: 5.691

Review 7.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

8.  A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.

Authors:  Timothy M Frayling; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Rachel M Freathy; Cecilia M Lindgren; John R B Perry; Katherine S Elliott; Hana Lango; Nigel W Rayner; Beverley Shields; Lorna W Harries; Jeffrey C Barrett; Sian Ellard; Christopher J Groves; Bridget Knight; Ann-Marie Patch; Andrew R Ness; Shah Ebrahim; Debbie A Lawlor; Susan M Ring; Yoav Ben-Shlomo; Marjo-Riitta Jarvelin; Ulla Sovio; Amanda J Bennett; David Melzer; Luigi Ferrucci; Ruth J F Loos; Inês Barroso; Nicholas J Wareham; Fredrik Karpe; Katharine R Owen; Lon R Cardon; Mark Walker; Graham A Hitman; Colin N A Palmer; Alex S F Doney; Andrew D Morris; George Davey Smith; Andrew T Hattersley; Mark I McCarthy
Journal:  Science       Date:  2007-04-12       Impact factor: 47.728

Review 9.  The role of microRNAs in cancer.

Authors:  Carlos E Stahlhut Espinosa; Frank J Slack
Journal:  Yale J Biol Med       Date:  2006-12

10.  The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.

Authors:  Thomas Gerken; Christophe A Girard; Yi-Chun Loraine Tung; Celia J Webby; Vladimir Saudek; Kirsty S Hewitson; Giles S H Yeo; Michael A McDonough; Sharon Cunliffe; Luke A McNeill; Juris Galvanovskis; Patrik Rorsman; Peter Robins; Xavier Prieur; Anthony P Coll; Marcella Ma; Zorica Jovanovic; I Sadaf Farooqi; Barbara Sedgwick; Inês Barroso; Tomas Lindahl; Chris P Ponting; Frances M Ashcroft; Stephen O'Rahilly; Christopher J Schofield
Journal:  Science       Date:  2007-11-08       Impact factor: 47.728

View more
  29 in total

Review 1.  Crosstalk between m6A regulators and mRNA during cancer progression.

Authors:  Xiaodong Niu; Yuan Yang; Yanming Ren; Shengtao Zhou; Qing Mao; Yuan Wang
Journal:  Oncogene       Date:  2022-08-25       Impact factor: 8.756

2.  FTO Regulates Apoptosis in CPB2-Treated IPEC-J2 Cells by Targeting Caspase 3 Apoptotic Protein.

Authors:  Jiaojiao Yang; Juanli Zhang; Xiaoli Gao; Ruirui Luo; Kaihui Xie; Wei Wang; Jie Li; Qiaoli Yang; Xiaoyu Huang; Zunqiang Yan; Pengfei Wang; Shuangbao Gun
Journal:  Animals (Basel)       Date:  2022-06-26       Impact factor: 3.231

Review 3.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

Review 4.  The emerging roles of N6-methyladenosine RNA methylation in human cancers.

Authors:  Huafei Shen; Yifen Lan; Yanchun Zhao; Yuanfei Shi; Jie Jin; Wanzhuo Xie
Journal:  Biomark Res       Date:  2020-06-29

5.  Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.

Authors:  Yan Geng; Renguo Guan; Weifeng Hong; Bowen Huang; Peizhen Liu; Xiaohua Guo; Shixiong Hu; Min Yu; Baohua Hou
Journal:  Ann Transl Med       Date:  2020-03

Review 6.  Methylation Landscape: Targeting Writer or Eraser to Discover Anti-Cancer Drug.

Authors:  Wen-Min Zhou; Bin Liu; Amin Shavandi; Lu Li; Hang Song; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

Review 7.  N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction.

Authors:  Jian Li; Fangjuan Wang; Yongkang Liu; Huaizhi Wang; Bing Ni
Journal:  Int J Biol Sci       Date:  2021-06-04       Impact factor: 6.580

Review 8.  Function and clinical significance of N6-methyladenosine in digestive system tumours.

Authors:  Junchao Huang; Yingjie Shao; Wendong Gu
Journal:  Exp Hematol Oncol       Date:  2021-07-10

9.  Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.

Authors:  Rui Su; Lei Dong; Yangchan Li; Min Gao; Li Han; Mark Wunderlich; Xiaolan Deng; Hongzhi Li; Yue Huang; Lei Gao; Chenying Li; Zhicong Zhao; Sean Robinson; Brandon Tan; Ying Qing; Xi Qin; Emily Prince; Jun Xie; Hanjun Qin; Wei Li; Chao Shen; Jie Sun; Prakash Kulkarni; Hengyou Weng; Huilin Huang; Zhenhua Chen; Bin Zhang; Xiwei Wu; Mark J Olsen; Markus Müschen; Guido Marcucci; Ravi Salgia; Ling Li; Amir T Fathi; Zejuan Li; James C Mulloy; Minjie Wei; David Horne; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-06-11       Impact factor: 38.585

10.  FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.

Authors:  Yudi Ding; Nana Qi; Ke Wang; Yiming Huang; Jinling Liao; Hongxue Wang; Aihua Tan; Lihua Liu; Zhenqiang Zhang; Jinlong Li; Jinliang Kong; Shouming Qin; Yonghua Jiang
Journal:  Onco Targets Ther       Date:  2020-02-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.